Skip to main content

Advertisement

SpringerLink
Log in

Synergy of 2-deoxy-d-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis

  • The many ways of apoptotic cell death
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Utilizing a variety of flow cytometric methods evidence was obtained indicating that a combination of the glucose analog 2-deoxy-d-glucose (2-dG) and the plant alkaloid berberine (BRB) produces synergistic effect in the induction of apoptosis in human lymphoblastoid TK6 cells. The synergistic effect is seen at concentrations of the drugs at which each of them alone shows no cytotoxicity at all. The data suggest that the combination of these drugs, which are known in terms of their overall toxicity, side effects and pharmacokinetics may be considered for further studies as chemopreventive and cancer treatment modalities. Of interest are results indicating that rapamycin, which similarly to BRB, suppresses mTOR signaling, when combined with 2-dG shows no synergistic properties. Metformin, on other hand, requires much higher concentration to show the synergy with 2-dG. Also of interest are the findings pertaining to the methodology of the present study. Specifically, dynamic assessment of cellular viability was performed by using the DRAQ7 cell exclusion fluorochrome present in cultures from 0 to 72 h. Concurrent measurement of lysosomal proton pump using acridine orange as the probe shows activation of lysosomes in the cells treated with 2-dG or BRB alone as well as with the drugs combined. Apoptosis was assessed by measuring DNA fragmentation, cell cycle, activation of caspase-3 and tissue transglutaminase (Tgase). A novel cytometric method was developed based on analysis of lysosomal (acidic vesicles) proton pump in live cells followed by cell lysis with detergent and fluorochrome labeling of proteins and DNA to analyze Tgase activation concurrently with cell cycle, in same population of cells. The data show that the cell subpopulation undergoing apoptosis has increased side (right-angle) light scatter likely due to the presence of the crosslinked (solid state) proteins, the consequence Tgase activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Austria)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kerr JFR, Wyllie AH, Curie AB (1972) Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Arends MJ, Morris RG, Wyllie AH (1990) Apoptosis. The role of endonuclease. Am J Pathol 136:593–608

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami, M. Traganos F (1997) Cytometry in cell necrobiology. Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1–20

    Article  CAS  PubMed  Google Scholar 

  4. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1–9

    Article  PubMed  Google Scholar 

  5. Zhivotovsky B (2004) Apoptosis, necrosis and between. Cell Cycle 3:64–66

    Article  CAS  PubMed  Google Scholar 

  6. Wlodkowic D, Skommer J, Darzynkiewicz Z (2012) Cytometry of apoptosis. Historical perspective and new advances. Exp Oncol 34:355–362

    Google Scholar 

  7. Wyllie AH, Golstein P (2001) More than one way to go. Proc Natl Acad Sci USA 98:11–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z (2011) Apoptosis and beyond: cytometry in studies of programmed cell death. Meth Cell Biol 103:55–98

    Article  CAS  Google Scholar 

  9. Wlodkowic D, Skommer J, Darzynkiewicz Z (2010) Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry A 77A:591–606

    Article  CAS  Google Scholar 

  10. Galluzzi L, Vitale I, Abrams JM et al (2012) Molecular definitions of cell death subroutines: recommendations on the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107–120

    Article  CAS  PubMed  Google Scholar 

  11. Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y (2014) 2-Deoxy-d-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett 28:176–183

    Article  Google Scholar 

  12. Kuntz S, Mazerbourg S, Boisbrun M, Cerella C, Diederich M, Grillier-Vuissoz I, Flament S (2014) Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones. Biochem Pharmacol 92:102–111

    Article  CAS  PubMed  Google Scholar 

  13. Xi H, Kurtoglu M, Lampidis TJ (2014) The wonders of 2-deoxy-d-glucose. IUBMB Life 66:110–121

    Article  CAS  PubMed  Google Scholar 

  14. Bost F, Decoux-Poullot AG, Tanti JF, Clavel S (2016) Energy disruptors: rising stars in anticancer therapy? Oncogenesis 18(5):e188

    Article  Google Scholar 

  15. Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M et al (2010) Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 70:1388–1394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wu H, Zhu H, Liu DX, Niu TK, Ren X et al (2009) Silencing of elongation Factor-2 kinase potentiates the effect of 2-deoxy-d-glucose against human glioma cells through blunting of autophagy. Cancer Res 69:2453–2460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kovács K, Decatur C, Toro M, Pham DG, Liu H, Jing Y, Murray TG, Lampidis TJ, Merchan JR (2016) 2-Deoxy-glucose downregulates endothelial AKT and ERK via interference with N-linked glycosylation, induction of endoplasmic reticulum stress, and GSK3β activation. Mol Cancer Ther 15:264–275

    Article  PubMed  Google Scholar 

  18. Liu H, Kurtoglu M, León-Annicchiarico CL, Munoz-Pinedo C, Barredo J, Leclerc G, Merchan J, Liu X, Lampidis TJ (2016) Combining 2-deoxy-d-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress. Oncotarget 7:36461–36473

    PubMed  PubMed Central  Google Scholar 

  19. Halicka HD, Ardelt B, Li X, Melamed MM, Darzynkiewicz Z (1995) 2-Deoxy-d-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res 55:444–449

    CAS  PubMed  Google Scholar 

  20. Chatterjee S, Thaker N, De A (2015) Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells. Breast Cancer (Dove Med Press) 31:251–265

    Google Scholar 

  21. Bikas A, Jensen K, Patel A, Costello J Jr, McDaniel D et al (2015) Glucose-deprivation increases thyroid cancer cells sensitivity to metformin. Endocr Relat Cancer 22:919–932

    Article  CAS  PubMed  Google Scholar 

  22. Fan LX, Liu CM, Gao AH, Zhou YB, Li J (2013) Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption. Biochim Biophys Acta 1830:5175–5183

    Article  CAS  PubMed  Google Scholar 

  23. Derosa G, Maffioli P, Cicero AF (2012) Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 12:1113-1124

    Article  Google Scholar 

  24. Caliceti C, Franco P, Spinozzi S, Roda A, Cicero AF (2016) Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Curr Med Chem 23:1460–1476

    Article  CAS  PubMed  Google Scholar 

  25. Wang N, Tan HY, Li L, Yuen MF, Feng Y (2015) Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives. J Ethnopharmacol 176:35–48

    Article  CAS  PubMed  Google Scholar 

  26. Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L, Li Q, Song Z, Fichna J (2015) A randomized clinical trial of berberine hydrochloride in patients with diarrhea predominant irritable bowel syndrome. Phytother Res 29:1822–1827

    Article  CAS  PubMed  Google Scholar 

  27. Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G (2015) Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol 23:69–81

    Article  Google Scholar 

  28. An Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M (2014) The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf) 80:425–431

    Article  CAS  Google Scholar 

  29. Li H, Miyahara T, Tezuka Y, Tran OL, Seto H, Kadota S (2003) Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biol Pharma Bull 26:130-131

    Google Scholar 

  30. Ki HF, Shen L (2011) Berberine: a potential multipotent natural product to combat Alzheimer’s disease. Molecules 16:6732-6740

    Google Scholar 

  31. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C et al (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344-1351

    Article  Google Scholar 

  32. Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H (2013) Berberine ameliorates experimental diabetes induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Mol Cell Endocrinol 381:56–65

    Article  CAS  PubMed  Google Scholar 

  33. Naveen CR, Gaikwad S, Agrawal-Rajput R (2016) Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells. Phytomedicine 23:736–744

    Article  CAS  PubMed  Google Scholar 

  34. Zhao Y, Jing Z, Li Y, Mao W (2016) Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol Rep 36:567–572

    PubMed  Google Scholar 

  35. Ortiz LMG, Lombardi P, Tillhon M, Scovassi AI (2014) Berberine, an epiphany against cancer. Molecules 19:12349–12367

    Article  PubMed  Google Scholar 

  36. Cai Y, Xia Q, Luo R, Huang P, Sun Y, Shi Y, Jiang W (2014) Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med 68:53–62

    Article  CAS  PubMed  Google Scholar 

  37. Halicka HD, Zhao H, Li J, Lee Y-S, Hsieh T-C, Wu JM, Darzynkiewicz Z (2012) Potential antiaging agents suppress the level of constitutive DNA damage- and mTOR- signaling. Aging 4:952–965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Zhao H, Halicka HD, Li J, Darzynkiewicz Z (2013) Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging 6:623–636

    Article  Google Scholar 

  39. Zhang Q, Bian H, Guo L, Zhu H (2016) Pharmacologic preconditioning with berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron. Am J Transl Res 8:1197–1207

    PubMed  PubMed Central  Google Scholar 

  40. Xue H, Ji Y, Wei S, Yu Y, Yan X, Liu S, Zhang M, Yao F, Lan X, Chen L (2016) HGSD attenuates neuronal apoptosis through enhancing neuronal autophagy in the brain of diabetic mice: the role of AMP-activated protein kinase. Life Sci 153:23–34

    Article  CAS  PubMed  Google Scholar 

  41. Guamán Ortiz LM, Croce AL, Aredia F, Sapienza S, Fiorillo G, Syeda TM, Buzzetti F, Lombardi P, Scovassi AI (2015) Effect of new berberine derivatives on colon cancer cells. Acta Biochim Biophys Sin (Shanghai) 47:824–833

    Article  Google Scholar 

  42. Darzynkiewicz Z, Kapuscinski J (1990) Acridine orange, a versatile probe of nucleic acids and other cell constituents. In: Melamed MR, Mendelsohn M, Lindmo T (eds) Flow cytometry and sorting. Alan R. Liss, Inc., New York, pp 291–314

    Google Scholar 

  43. Traganos F, Darzynkiewicz Z (1994) Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Meth Cell Biol 41:185–194.

    Article  CAS  Google Scholar 

  44. Pierzyńska-Mach A, Janowski PA, Dobrucki JW (2014) Evaluation of acridine orange, LysoTracker Red, and quinacrine as fluorescent probes for long-term tracking of acidic vesicles. Cytometry A 85:729–737

    Article  PubMed  Google Scholar 

  45. Kusuzaki K, Hosogi S, Ashihara E, Matsubara T et al (2012) Translational research of photodynamic therapy with acridine orange which targets cancer acidity. Curr Pharm Des 18:1414–1420

    Article  CAS  PubMed  Google Scholar 

  46. Manente S, De Pieri S, Iero A, Rigo C, Bragadin M (2008) A comparison between the responses of neutral red and acridine orange: acridine orange should be preferential and alternative to neutral red as a dye for the monitoring of contaminants by means of biological sensors. Anal Biochem 383:316–319

    Article  CAS  PubMed  Google Scholar 

  47. Fotia C, Avnet S, Kusuzaki K, Roncuzzi L, Baldini N (2015) Acridine orange is an effective anti-cancer drug that affects mitochondrial function in osteosarcoma cells. Curr Pharm Des 21:4088–4094

    Article  CAS  PubMed  Google Scholar 

  48. Darzynkiewicz Z, Juan G, Srour EF (2004) Differential staining of DNA and RNA. Curr Protoc Cytom. doi:10.1002/0471142956.cy0703s30

    Google Scholar 

  49. Darzynkiewicz, Z (1990) Differential staining of DNA and RNA in intact cells and isolated cell nuclei with acridine orange. Meth in Cell Biol 33:285–298

    Article  CAS  Google Scholar 

  50. Mindell JA (2012) Lysosomal acidification mechanisms. Annu Rev Physiol 74:69–86

    Article  CAS  PubMed  Google Scholar 

  51. Grabarek J, Ardelt B, Kunicki J, Darzynkiewicz Z (2002) Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry. Cytometry 49:83–99

    Article  CAS  PubMed  Google Scholar 

  52. Wlodkowic D, Akagi J, Dobrucki J, Errington R, Smith PJ, Takeda K, Darzynkiewicz Z (2013) Kinetic viability assays using DRAQ7 probe. Curr Protoc Cytom. doi:10.1002/0471142956.cy0941s65

    PubMed Central  Google Scholar 

  53. Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z (2007) Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub-G1″ peaks on DNA content histograms. Cytometry A 71A:125–131

    Article  CAS  Google Scholar 

  54. Kim SA, Kwon Y, Kim JH, Muller MT, Chung IK (1998) Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine. BioChemistry 37:16316–16324

    Article  CAS  PubMed  Google Scholar 

  55. Krishnan P, Bastow KF (2000) The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. Anticancer Drug Des 15:255–264

    CAS  PubMed  Google Scholar 

  56. Sun Y, Xun K, Wang Y, Chen X (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20:757–769

    Article  CAS  PubMed  Google Scholar 

  57. Li W, Hua B, Saud SM, Lin H, Hou W, Matter MS, Jia L, Colburn NH, Young MR (2015) Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol Carcinog 54:1096–1109

    Article  CAS  PubMed  Google Scholar 

  58. Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, Tsao SW (2010) Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 111:1426–1436

    Article  CAS  PubMed  Google Scholar 

  59. Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, Chen M, Su H, Li P, Wan JB, He C (2016) Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 6:26064

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Darzynkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coico L, Melamed MR (1984) Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry 5:355–363

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Supported by the Robert A. Welke Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Department of Pathology, Brander Cancer Research Institute, New York Medical College, BSB 438, Valhalla, NY, 10595, USA

    H. Dorota Halicka, Jorge Garcia, Jiangwei Li, Hong Zhao & Zbigniew Darzynkiewicz

Authors
  1. H. Dorota Halicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiangwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zbigniew Darzynkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zbigniew Darzynkiewicz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Halicka, H.D., Garcia, J., Li, J. et al. Synergy of 2-deoxy-d-glucose combined with berberine in inducing the lysosome/autophagy and transglutaminase activation-facilitated apoptosis. Apoptosis 22, 229–238 (2017). https://doi.org/10.1007/s10495-016-1315-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-016-1315-5

Keywords

Search

Navigation